EPYC and prostate carcinoma: Moreover, NSAIDS drugs, as the first-line treatment for OA, have been proven effective in curbing the expression of EPYC in prostate cancer cells [46], but their effects on EPYC gene expression in OA articular chondrocytes should be further explored.